LSI Medience Corporation

Site

Anti-Doping Laboratory

Accreditation No.

14243

Site No.

14236

Date of Accreditation

09 Aug 1999

Address

1-15-10 Shimura,, Itabashi-ku,, TOKYO 174-0056
0
Japan

medience.co.jp

Contact

Ms Ayako Ikekita P: 81 359942360

Availability

Services conditionally available to external clients

LSI Medience Corporation address map

Scope of Accreditation

Print scopes
Anti-Doping Laboratory

ISO/IEC 17025 (2017)

Legal - Analysis for compliance with WADA and sporting federation requirements

  • This facility complies with the requirements of the World Anti-Doping Agency (WADA) International Standard for Laboratories (ISL) (January 2021)
Service Product Determinant Technique Procedure
Analysis for sports drugs and drug metabolites Dried blood spots S1: Anabolic agents Derivatization; LC-MSn (n≥1) in-house method TK-3B-39: Qualitative CP
Dried blood spots; Human blood; Human urineHuman Blood cell fraction M3 Gene and cell doping Polymerase chain reaction (PCR)Polymerase chain reaction(PCR) /DNA sequencing In-house method TK-3B-55
Human blood M1: Manipulation of blood and blood components (hemoglobin-based oxygen carriers) Enzymatic digestion; LC-MSn (n≥1); Precipitation; Visual examination in-house methods TK-3B-29: Qualitative CP, TK-3B-50:ITP
Blood parameters Flow cytometry

in-house method TK-3B-27: Quantitative CP
M3 Gene and cell doping Polymerase chain reaction (PCR) in-house method TK-3B-35:Qualitative CP
M1: Manipulation of blood and blood components Flow cytometry in-house method TK-3B-28 ITP, Qualitative CP
Human plasma; Human serum; Human urine S2: Peptide hormones, growth factors, related substances, and mimetics (erythropoiesis stimulating agents - SAR-PAGE, IEF-PAGE) Gel electrophoresis; Ultrafiltration (UF) in-house methods TK-3B-13, TK-3B-36: ITP, Qualitative CP
Human serum Human growth hormone (HGH) biomarkers; S2: Peptide hormones, growth factors, related substances, and mimetics Chemiluminescent immunoassay (CLIA); LC-HRMSn (n≥1); Precipitation in-house methods TK-3B-52, TK-3B-53; ITP, Quantitative CP
S2: Peptide hormones, growth factors, related substances, and mimetics (human growth hormone - isoform) Affinity-binding assay in-house methods TK-3B-43: ITP, Quantitative CP
S1: Anabolic agents (including steroid profiling) LC-MSn (n≥1); Solid phase extraction (SPE) in-house method TK-3B-47: ITP, Quantitative CP
Human urine S2: Peptide hormones, growth factors, related substances, and mimetics Dilute and shoot; Enzymatic hydrolysis; Immunopurification; LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE); Ultrafiltration (UF) in-house methods TK-3B-06, TK3B-07: ITP
TK-3B-15: Qualitative CP,
TK-3B-12:Qualitative CP
S4: Hormone and metabolic modulators Immunopurification; LC-HRMSn (n≥1); Ultrafiltration (UF) In-house method TK-3B-12 Qualitative CP
S8: Cannabinoids Chemical hydrolysis; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) in-house methods:
TK-3B-06, TK-3B-10: ITP
TK-3B-25:Quantitative CP,
TK-3B-15:Qualitative CP
S1: Anabolic agents (including steroid profiling) Chiral separation; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) in-house methods:
TK-3B-06, TK-3B-10: ITP
TK-3B-02, TK-3B-14, TK-3B-15, TK-3B-16,TK-3B-17, TK-3B-20, TK-3B-21: Qualitative CP
TK-3B-19: Quantitative CP
S4: Hormone and metabolic modulators Chiral separation; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) in-house methods TK-3B-06, TK-3B-08, TK-3B-10:ITP
TK-3B-15, TK-3B-16; Qualitative CP
S7: Narcotics Chiral separation; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) in-house methods
TK-3B-06, TK-3B-08, TK-3B-10: ITP
TK-3B-15, TK-3B-16;Qualitative CP
TK-3B-26: Quantitative CP
S9: Glucocorticoids Dilute and shoot; Enzymatic hydrolysis; LC-HRMSn (n≥1); LC-MS-MS; LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) in-house method TK-3B-06:ITP
TK-3B-15:Qualitative CP
S2: Peptide hormones, growth factors, related substances, and mimetics (chorionic gonadotrophin and luteinizing hormone) Affinity-binding assay in-house methods TK-3B-09: ITP; TK-3B-18: Quantitative CP
S3: Beta-2 agonists Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) in-house method
TK-3B-06, TK-3B-10: ITP
TK-3B-15, Qualitative CP
TK-3B-23, TK-3B-24:Quantitative CP
pH Potentiometry in-house method TK-3B-40, TK-3B-54
S6: Stimulants Chiral separation; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) in-house methods
TK-3B-06, TK-3B-08, TK-3B-10: ITP
TK-3B-15, TK-3B-16: Qualitative CP
TK-3B-22: Quantitative CP
Specific gravity Refractometry in-house method TK-3B-41, TK-3B-54: ITP, Quantitative CP
P1: Beta-blockers Dilute and shoot; Enzymatic hydrolysis; LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) in-house methods TK-3B-06: ITP
TK-3B-15: Qualitative CP
S5: Diuretics and masking agents Dilute and shoot; Enzymatic hydrolysis; LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) in-house methods TK-3B-06, TK-3B-07:ITP
TK-3B-15: Qualitative CP

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.